Home / Market Reports / Medical Devices & Consumables / Global Peptide API CDMO Services Market Growth (Status and Outlook) 2024-2030

Global Peptide API CDMO Services Market Growth (Status and Outlook) 2024-2030

Global Peptide API CDMO Services Market Growth (Status and Outlook) 2024-2030

Product Code:981512

Published Date: Jun 20,2024

Pages: 104

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US 

Peptide API CDMO (Contract Development and Manufacturing Organization) Services refer to the specialized services provided by companies that offer comprehensive support for the development, manufacturing, and production of peptide active pharmaceutical ingredients (APIs). These services are essential for the pharmaceutical and biotechnology industries, facilitating the production of peptides for therapeutic purposes.

The global Peptide API CDMO Services market size is projected to grow from US$ 2291 million in 2024 to US$ 5489 million in 2030; it is expected to grow at a CAGR of 15.7% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Peptide API CDMO Services Industry Forecast” looks at past sales and reviews total world Peptide API CDMO Services sales in 2022, providing a comprehensive analysis by region and market sector of projected Peptide API CDMO Services sales for 2023 through 2029. With Peptide API CDMO Services sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Peptide API CDMO Services industry.

This Insight Report provides a comprehensive analysis of the global Peptide API CDMO Services landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Peptide API CDMO Services portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Peptide API CDMO Services market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Peptide API CDMO Services and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Peptide API CDMO Services.

Global key players of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, Thermo Fisher, etc. The top five players hold a share over 54%. North America is the largest market, and has a share about 52%, followed by Europe and China with share 33% and 9%, separately. In terms of product type, GMP Services is the largest segment, occupied for a share of 72%. In terms of application, Commercial has a share about 75 percent.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide API CDMO Services market by product type, application, key players and key regions and countries.

Segmentation by Type:
    GMP Services
    Non-GMP Services

Segmentation by Application:
    Commercial
    Scientific Research
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

Segmentation by Type:
    GMP Services
    Non-GMP Services

Segmentation by Application:
    Commercial
    Scientific Research
    Other

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
    Bachem
    PolyPeptide
    CordenPharma
    AmbioPharm
    USV Peptides
    Thermo Fisher
    Bio Basic
    JPT
    Genscript
    Chinese Peptide Company
    ScinoPharm
    ChengDu ShengNuo Biotec
    CBL
    Piramal Pharma
    CPC Scientific